An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot Testosterone 50 mg, 75 mg, or 100 mg by Intended Users and QuickShot Summative Usability Study

Trial Profile

An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot Testosterone 50 mg, 75 mg, or 100 mg by Intended Users and QuickShot Summative Usability Study

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Testosterone enanthate (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions
  • Sponsors Antares Pharma
  • Most Recent Events

    • 28 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 16 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Jun 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top